[the_ad_placement id=”adsense-in-feed”]
India registers the highest single day recovery of 73,642 patients in the last 24 hours
New Delhi: As Russia released first batch of Covid-19 vaccine – Sputnik V – into public today, it also requested India’s help in manufacturing of vaccine by Indian companies and conduct of Phase-III studies in India, Dr. V.K Paul, Member (Health), NITI Aayog informed on Tuesday.
“We are working with this vaccine candidate for manufacture as well as trial and regulatory facilitation, in the spirit of partnership and science for humanity,” he said, adding that the outreach has been extended to the vaccine manufacturers in India and about four of them had already come forward while others were in talks with the Russian counterparts.
[the_ad_placement id=”content-placement-after-3rd-paragraph”]
“India attaches high importance to the request from a special friend and on both fronts, there has been considerable progress,” he said.
While the Government was facilitating that process of creating a connect, Dr. Paul said they might be specific outcomes very soon in that regard.
“This is a win-win situation for India and the world, indeed. India can manufacture that vaccine in large and significant quantities. On the regulatory front, Indian scientists have looked at the data. There would be a need for Phase III trials in normal course of things,” he stated.
In the meantime, Dr. Paul expressed concerns over people not practising discipline and warned that if they adopt lax behaviour, it would make it easier for COVID-19 virus to spread. “We are getting complaints from State governments that people have become lax in following COVID-appropriate behaviours,” he disclosed and cautioned that it was even more important today “that we continue to follow precautionary behaviours against COVID-19”. He added, it is primarily an individual’s responsibility to keep the virus away from one’s self, while the system’s responsibility is to carry out containment measures, contact tracing, surveillance and so on. He further said, “Our treatment protocols have been evolved in a very good manner, based on our progressive understanding of the pandemic; we have now become confident of our protocol; hence, we appeal that the treatment protocol is followed meticulously by everyone. Especially for people residing in rural areas, it is more important that the patient and family take prompt action to do testing, on appearance of symptoms”.
Dr. Paul also appealed to all to wear masks, maintain social distancing, avoid large gatherings and take immunity boosting measures all the more. “These still remain the key of slowing and controlling a pandemic,” he said.
Meanwhile, the government said more than 5 crore tests had been conducted so far, taking India to the second highest position in terms of testing. More than 10 lakh tests had been conducted daily in this week. At the same time, the number of recovered patients was more than 33 lakhs now, and, the highest single day recovery of 73,642 patients had also been recorded in the last 24 hours.
Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu were the five states which account for 62% of the active cases. Nearly 70% of the COVID-19 related deaths were also being reported from 5 states, that is, Maharashtra, Tamil Nadu, Karnataka, Andhra Pradesh and Uttar Pradesh.
Maharashtra’s share was around 27% of the total active cases, which in terms of absolute numbers was 2.37 lakhs. On the other hand, there were 14 states and UTs which have less than 5,000 active cases at present.
There are also 20 states and UTs where the number of active cases are between 2,000-5,000, the Union Health Ministry informed.
In the last 24 hours 75809 frest Corona cases were reported in the country taking the overall total to 4280422. In all 1133 deaths were reported in the country which took the death toll because of COVID-19 to 72775 so far.
Meanwhile the Review Committee of the International Health Regulations was scheduled to begin its work from today to evaluate the functioning of the IHR during the pandemic so far, and recommend any changes it believes are necessary. It will review the convening of the Emergency Committee, the declaration of a public health emergency of international concern, the role and functioning of national IHR focal points, and will examine progress made in implementing the recommendations of previous International Health Regulations review committees.
Depending on progress made, the committee was likely to present an interim progress report to the resumed World Health Assembly in November, and a final report to the Assembly in May next year.
“The committee will also communicate as needed with other review bodies, including the Independent Panel for Pandemic Preparedness and Response – IPPR – and the Independent Oversight Advisory Committee – IOAC – for the WHO Health Emergencies Programme,” Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO, informed mediapersons last night.
– globalbihari bureau
[the_ad_placement id=”sidebar-feed”]
